Abbott announced today that the FDA approved its CardioMEMS Hero next-generation pulmonary artery (PA) pressure reader.

Abbott has secured the US Food and Drug Administration (FDA) approval for its next-generation CardioMEMS HERO device, which ...

Recent developments of interest in cardiovascular medicine ...

Recent developments of interest in cardiovascular medicine ...

The Food and Drug Administration awarded approval to CardioMEMS Hero, a new version of the device that patients use to take daily pulmonary artery pressure readings. Abbott has made Hero smaller and ...

Relief Cardiovascular, Inc., a private medical device company developing intelligent device-based therapy solutions for heart failure (HF) congestion, today announced positive 90-day results from the ...

The new Lancia is expected to debut later this year, with electric and hybrid powertrain options topped by a performance-focused HF version ...

Heart disease is the leading cause of death in the United States so UNC Heart and Vascular is expanding to meet the growing need for heart care in Caldwell County and beyond. UNC Heart and Vascular ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The DGK, as anticipated, can carry a DS8 SDV developed and built also by Drass, of which two were recently delivered to the Indonesian Navy, out of a planned component of six, according to information ...

Abbott’s CardioMEMS™ HERO is a compact remote reader that is 60% lighter compared to its previous generation device for heart failure patients with Abbott’s CardioMEMS pulmonary artery pressure sensor ...

GA, UNITED STATES, February 19, 2026 /EINPresswire.com/ — Continuous cardiovascular monitoring is vital for preventing and managing heart disease, yet most wearable ...